Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
6-Gingerol is the major bioactive phenolic compound found in the rhizome of ginger (Zingiber officinale). Structurally, it is characterized by a 4-hydroxy-3-methoxyphenyl group substituted at the C6 carbon by a 5-hydroxy-alkane-3-one side chain, with a chemical formula of C₁₇H₂₆O₄. It is responsible for the characteristic pungency of fresh ginger and exhibits diverse biological activities, including anti-inflammatory, antioxidant, and anti-tumor effects in preclinical models. [6]-Gingerol is not a therapeutic target itself, but rather a bioactive small molecule studied for its health benefits and mechanisms of action in cell signaling, inflammation, and metabolic regulation[1][2][3][4][5][6].
As an active component, gingerol can inhibit adipogenesis, exert anti-inflammatory and antioxidant effects, and may act on molecular pathways relevant to cancer, such as inhibition of NF-κB, COX-2, and regulation of cellular signaling[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 6-Gingerol.